1. Academic Validation
  2. NAD+ Repletion Reverses Heart Failure With Preserved Ejection Fraction

NAD+ Repletion Reverses Heart Failure With Preserved Ejection Fraction

  • Circ Res. 2021 May 28;128(11):1629-1641. doi: 10.1161/CIRCRESAHA.120.317046.
Dan Tong 1 Gabriele G Schiattarella 1 Nan Jiang 1 Francisco Altamirano 1 Pamela A Szweda 1 Abdallah Elnwasany 1 Dong I Lee 2 Heesoo Yoo 1 David A Kass 2 Luke I Szweda 1 Sergio Lavandero 1 3 Eric Verdin 4 Thomas G Gillette 1 Joseph A Hill 1 5
Affiliations

Affiliations

  • 1 Internal Medicine (Cardiology) (D.T., G.G.S., N.J., F.A., P.A.S., A.E., H.Y., L.I.S., S.L., T.G.G., J.A.H.), University of Texas Southwestern Medical Center, Dallas, TX.
  • 2 Department of Medicine (Cardiology), Johns Hopkins University School of Medicine, Baltimore MD (D.I.K., D.A.K.).
  • 3 Advanced Center for Chronic Diseases (ACCDiS) & Corporacion Estudios Cientificos de las Enfermedades Cronicas (CECEC), Faculty of Chemical & Pharmaceutical Sciences & Faculty of Medicine, University of Chile, Santiago (S.L.).
  • 4 Bulk Institute for Research on Aging, Novato, CA (E.V.).
  • 5 Molecular Biology (J.A.H.), University of Texas Southwestern Medical Center, Dallas, TX.
Abstract

[Figure: see text].

Keywords

NAD; acetylation; cardiomyopathy; heart failure; mitochondria.

Figures
Products